1-7 of 7
Vishvdeep Khushoo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase-3 study of vamotinib (PF-114) versus high-dose imatinib

Free
Anna Turkina, Olga Vinogradova, Nuriya Kalimulina, Tatyana Shelekhova, Igor Davydkin, Bulat Bakirov, Tatiana Pospelova, Elza Lomaia, Jitendra Pehalajani, Vishvdeep Khushoo, Shashikant Apte, Robert Gale, Ghermes Chilov
Journal: Blood
Blood (2025) 146 (Supplement 1): 7290.
https://doi.org/10.1182/blood-2025-7290
Published: 2025
Journal Articles

Busulfan (Bu) and Cyclophosphamide (Cy) Based Conditioning Regimen Still Holds the Promise of Being a Safe and Efficacious Regimen for Allogeneic Transplantation in Patients with Transfusion Dependent Thalassemia (TDT) Even in High Risk

Free
Pallavi Mehta, Aakanksha A Singh, Neha Yadav, Narendra Agrawal, Rayaz Ahmed, Vishvdeep Khushoo, Dinesh Bhurani
Journal: Blood
Blood (2021) 138 (Supplement 1): 949.
https://doi.org/10.1182/blood-2021-150358
Published: 2021
Journal Articles

Individualized AML Induction with Venetoclax Based Therapy in Unfit Treatment Naïve Patients Aged ≤ 60 Years: A Real World Perspective from India

Free
Mohd Rizwan Mohamad Anwar Shaikh, Pallavi Mehta, Sumeet Prakash Mirgh, Rohan Halder, Narendra Agrawal, Vishvdeep Khushoo, Rayaz Ahmed, Bhaarat Folbs, Divya Pratihast, Nitin Bansal, Dinesh Bhurani
Journal: Blood
Blood (2021) 138 (Supplement 1): 4417.
https://doi.org/10.1182/blood-2021-150435
Published: 2021
Journal Articles

Combination of Venetoclax and Hypomethylating Agents in Myeloid Malignancies in Patients Unfit for Intensive Chemotherapy - Real World Data from a Tertiary Care Centre in India. Is It Time to Bid Adieu to 3+7?

Free
Sumeet Prakash Mirgh, MBBS, MDDM, Jyotsna Kapoor, MSc, Shinto Francis Thekuddan, MD DM, Vishvdeep Khushoo, MBBS, MDDM, Faran Naim, MD DNB, Ambar Garg, MD DNB, Narendra Agrawal, MD DM, Rayaz Ahmed, MDDM, Dinesh Bhurani, MD DM, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5149.
https://doi.org/10.1182/blood-2019-131746
Published: 2019
Journal Articles

Experience with Low Dose Thalidomide in Transfusion Dependent Beta Thalassaemia in a Resource Limited Setting

Free
Pallavi Mehta, MD DM, Neha Yadav, BDS , MBA, Priyanka Soni, MD FNB, Shinto Francis Thekuddan, MBBS,MDDM, Reema Singh, MSc, Vishvdeep Khushoo, MBBS,MDDM, Sumeet Prakash Mirgh, MBBS,MDDM, Narendra Agrawal, MD DM, Rayaz Ahmed, MDDM, Jyotsna Kapoor, MSc, Dinesh Bhurani, MD DM, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 963.
https://doi.org/10.1182/blood-2019-131682
Published: 2019
Journal Articles

Carfilzomib-Pomalidomide-Dexamethasone (KPD) in Relapsed/Refractory Multiple Myeloma Patients - an Institutional Retrospective Analysis

Free
Pallavi Mehta, MD DM, Neha Yadav, BDS , MBA, Mohan Bhaarat, Sumeet Prakash Mirgh, MBBS, MDDM, Vishvdeep Khushoo, MBBS, MDDM, Shinto Francis Thekuddan, MBBS, MDDM, Narendra Agrawal, MD DM, Rayaz Ahmed, MDDM, Dinesh Bhurani, MD DM, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5572.
https://doi.org/10.1182/blood-2019-131674
Published: 2019
Journal Articles

Effect of Depression on Health Related Quality of Life and Adherence and Its Correlation with Response Rates in Patients of Chronic Myeloid Leukemia on First Line Imatinib and Nilotinib - a Prospective, Institutional Analysis of Real World Data from India

Free
Pratibha Bhatia, MSc, BSc, Sumeet Prakash Mirgh, MBBS,MDDM, Vishvdeep Khushoo, MBBS,MDDM, Faran Naim, MD DNB, Ambar Garg, MD DNB, Rayaz Ahmed, MDDM, Narendra Agrawal, MD DM, Dinesh Bhurani, MD DM, FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 3500.
https://doi.org/10.1182/blood-2019-131763
Published: 2019